Clinical Trial Update: Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy (ALTER-L006) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating anlotinib in elderly patients with advanced non-squamous non-small cell lung cancer who have not received systemic ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: LanZhou University | Conditions: Advanced Non-squamous NSCLC | Phase 4 | Status: UNKNOWN